Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Current Assets of $43.1 million for Q1 2026, up 2493.48% on a YoY basis from $1.7 million in Q1 2025, and up 147.81% quarter-over-quarter from $17.4 million in Q4 2025.
Canton Strategic Holdings (CNTN) Current Assets (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Current Assets for 7 years, with the latest figure at $43.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 2493.48% year-over-year to $43.1 million; the trailing twelve-month figure through Mar 2026 stood at $43.1 million (up 2493.48% YoY), and the FY2025 full-year result was $17.4 million, up 367.16% from the prior year.
- Current Assets for Q1 2026 stood at $43.1 million, up from $17.4 million in the prior quarter.
- The five-year high for Current Assets was $43.1 million in Q1 2026, with the low at $1.7 million in Q1 2025.
- Historically, Current Assets has averaged $9.4 million across 5 years, with a median of $7.7 million in 2025.
- Annual changes were most pronounced in 2025 — Current Assets plunged 81.31% — and 2026, when it jumped 2493.48%.
- Canton Strategic Holdings' Current Assets stood at $6.7 million in 2022, then surged by 63.66% to $10.9 million in 2023, then plunged by 66.0% to $3.7 million in 2024, then jumped by 367.16% to $17.4 million in 2025, then jumped by 147.81% to $43.1 million in 2026.
- The last three Current Assets figures came in at $43.1 million (Q1 2026), $17.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | 43.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.09 Mn |
| Dec 31, 2025 | 17.39 Mn |
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Mar 31, 2024 | 8.89 Mn |
| Dec 31, 2023 | 10.95 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 4.72 Mn |
| Dec 31, 2022 | 6.69 Mn |
| Sep 30, 2022 | 8.02 Mn |
| Jun 30, 2022 | 10.25 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 621,677.00 |
| Dec 31, 2020 | 294,798.00 |